Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License...